vs
Side-by-side financial comparison of BCB BANCORP INC (BCBP) and Electromed, Inc. (ELMD). Click either name above to swap in a different company.
BCB BANCORP INC is the larger business by last-quarter revenue ($26.2M vs $18.9M, roughly 1.4× Electromed, Inc.). Electromed, Inc. runs the higher net margin — 14.6% vs -49.7%, a 64.3% gap on every dollar of revenue. On growth, Electromed, Inc. posted the faster year-over-year revenue change (16.3% vs 13.1%). BCB BANCORP INC produced more free cash flow last quarter ($34.9M vs $2.4M). Over the past eight quarters, Electromed, Inc.'s revenue compounded faster (16.7% CAGR vs 1.8%).
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
BCBP vs ELMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $26.2M | $18.9M |
| Net Profit | $-12.0M | $2.8M |
| Gross Margin | — | 78.4% |
| Operating Margin | -71.9% | 19.2% |
| Net Margin | -49.7% | 14.6% |
| Revenue YoY | 13.1% | 16.3% |
| Net Profit YoY | -467.6% | 40.3% |
| EPS (diluted) | $-0.73 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.2M | $18.9M | ||
| Q3 25 | $26.5M | $16.9M | ||
| Q2 25 | $25.2M | $17.4M | ||
| Q1 25 | $23.8M | $15.7M | ||
| Q4 24 | $23.1M | $16.3M | ||
| Q3 24 | $26.2M | $14.7M | ||
| Q2 24 | $20.4M | $14.8M | ||
| Q1 24 | $25.3M | $13.9M |
| Q4 25 | $-12.0M | $2.8M | ||
| Q3 25 | $4.3M | $2.1M | ||
| Q2 25 | $3.6M | $2.2M | ||
| Q1 25 | $-8.3M | $1.9M | ||
| Q4 24 | $3.3M | $2.0M | ||
| Q3 24 | $6.7M | $1.5M | ||
| Q2 24 | $2.8M | $1.8M | ||
| Q1 24 | $5.9M | $1.5M |
| Q4 25 | — | 78.4% | ||
| Q3 25 | — | 78.1% | ||
| Q2 25 | — | 78.3% | ||
| Q1 25 | — | 78.0% | ||
| Q4 24 | — | 77.7% | ||
| Q3 24 | — | 78.3% | ||
| Q2 24 | — | 76.2% | ||
| Q1 24 | — | 74.8% |
| Q4 25 | -71.9% | 19.2% | ||
| Q3 25 | 21.9% | 15.8% | ||
| Q2 25 | 19.9% | 17.5% | ||
| Q1 25 | -49.2% | 13.6% | ||
| Q4 24 | 19.9% | 15.6% | ||
| Q3 24 | 35.7% | 13.2% | ||
| Q2 24 | 19.5% | 15.7% | ||
| Q1 24 | 33.0% | 13.3% |
| Q4 25 | -49.7% | 14.6% | ||
| Q3 25 | 16.1% | 12.6% | ||
| Q2 25 | 14.2% | 12.7% | ||
| Q1 25 | -35.0% | 12.1% | ||
| Q4 24 | 14.1% | 12.1% | ||
| Q3 24 | 25.5% | 10.0% | ||
| Q2 24 | 13.8% | 12.3% | ||
| Q1 24 | 23.2% | 10.8% |
| Q4 25 | $-0.73 | $0.32 | ||
| Q3 25 | $0.22 | $0.25 | ||
| Q2 25 | $0.18 | $0.26 | ||
| Q1 25 | $-0.51 | $0.21 | ||
| Q4 24 | $0.17 | $0.22 | ||
| Q3 24 | $0.36 | $0.16 | ||
| Q2 24 | $0.14 | $0.20 | ||
| Q1 24 | $0.32 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $13.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $304.3M | $45.4M |
| Total Assets | $3.3B | $54.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $13.8M | ||
| Q3 25 | — | $14.1M | ||
| Q2 25 | — | $15.3M | ||
| Q1 25 | — | $15.2M | ||
| Q4 24 | — | $16.2M | ||
| Q3 24 | — | $13.9M | ||
| Q2 24 | — | $16.1M | ||
| Q1 24 | — | $11.7M |
| Q4 25 | $304.3M | $45.4M | ||
| Q3 25 | $318.5M | $44.7M | ||
| Q2 25 | $315.7M | $43.2M | ||
| Q1 25 | $314.7M | $43.9M | ||
| Q4 24 | $323.9M | $43.6M | ||
| Q3 24 | $328.1M | $41.5M | ||
| Q2 24 | $320.7M | $44.5M | ||
| Q1 24 | $320.1M | $42.5M |
| Q4 25 | $3.3B | $54.9M | ||
| Q3 25 | $3.4B | $53.6M | ||
| Q2 25 | $3.4B | $53.8M | ||
| Q1 25 | $3.5B | $52.5M | ||
| Q4 24 | $3.6B | $52.3M | ||
| Q3 24 | $3.6B | $48.9M | ||
| Q2 24 | $3.8B | $52.2M | ||
| Q1 24 | $3.8B | $48.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $35.9M | $3.0M |
| Free Cash FlowOCF − Capex | $34.9M | $2.4M |
| FCF MarginFCF / Revenue | 133.3% | 12.7% |
| Capex IntensityCapex / Revenue | 4.0% | 3.4% |
| Cash ConversionOCF / Net Profit | — | 1.10× |
| TTM Free Cash FlowTrailing 4 quarters | $58.2M | $7.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.9M | $3.0M | ||
| Q3 25 | $8.7M | $169.0K | ||
| Q2 25 | $10.3M | $3.9M | ||
| Q1 25 | $5.0M | $2.1M | ||
| Q4 24 | $67.7M | $3.2M | ||
| Q3 24 | $43.5M | $2.3M | ||
| Q2 24 | $8.1M | $4.5M | ||
| Q1 24 | $8.3M | $1.4M |
| Q4 25 | $34.9M | $2.4M | ||
| Q3 25 | $8.5M | $-83.0K | ||
| Q2 25 | $10.2M | $3.7M | ||
| Q1 25 | $4.7M | $1.9M | ||
| Q4 24 | $66.5M | $2.9M | ||
| Q3 24 | $43.4M | $2.3M | ||
| Q2 24 | $8.1M | $4.5M | ||
| Q1 24 | $8.1M | $1.3M |
| Q4 25 | 133.3% | 12.7% | ||
| Q3 25 | 32.0% | -0.5% | ||
| Q2 25 | 40.4% | 21.4% | ||
| Q1 25 | 19.8% | 12.2% | ||
| Q4 24 | 287.5% | 18.0% | ||
| Q3 24 | 166.0% | 15.5% | ||
| Q2 24 | 39.6% | 30.1% | ||
| Q1 24 | 32.3% | 9.1% |
| Q4 25 | 4.0% | 3.4% | ||
| Q3 25 | 1.1% | 1.5% | ||
| Q2 25 | 0.6% | 0.8% | ||
| Q1 25 | 1.2% | 1.0% | ||
| Q4 24 | 5.3% | 1.4% | ||
| Q3 24 | 0.3% | 0.3% | ||
| Q2 24 | 0.2% | 0.1% | ||
| Q1 24 | 0.6% | 0.6% |
| Q4 25 | — | 1.10× | ||
| Q3 25 | 2.05× | 0.08× | ||
| Q2 25 | 2.90× | 1.75× | ||
| Q1 25 | — | 1.10× | ||
| Q4 24 | 20.70× | 1.60× | ||
| Q3 24 | 6.53× | 1.57× | ||
| Q2 24 | 2.88× | 2.46× | ||
| Q1 24 | 1.41× | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCBP
Segment breakdown not available.
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
